These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33504611)

  • 1. Why the Maternal Medication List Matters: Neonatal Toxicity From Combined Serotonergic Exposures.
    Brajcich MR; Palau MA; Messer RD; Murphy ME; Marks J
    Pediatrics; 2021 Feb; 147(2):. PubMed ID: 33504611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal venlafaxine discontinuation syndrome: A mini-review.
    Holland J; Brown R
    Eur J Paediatr Neurol; 2017 Mar; 21(2):264-268. PubMed ID: 27931774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin syndrome after electroconvulsive therapy in a patient on trazodone, bupropion, and quetiapine: a case report.
    Cheng YC; Liang CM; Liu HC
    Clin Neuropharmacol; 2015; 38(3):112-3. PubMed ID: 25970280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor neonatal adaptation following in-utero exposure to quetiapine and lamotrigine.
    Lau C; Watson H; Cheong J
    J Obstet Gynaecol; 2015; 35(6):646. PubMed ID: 25642636
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversible dyskinesia during bupropion therapy.
    Gardos G
    J Clin Psychiatry; 1997 May; 58(5):218. PubMed ID: 9184616
    [No Abstract]   [Full Text] [Related]  

  • 6. Mania induced by tramadol-venlafaxine combination.
    Hefzi N; Grekin J; Ahmed A
    J Opioid Manag; 2019; 15(4):342-344. PubMed ID: 31637686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Quetiapine Withdrawal Syndrome with Nausea and Vomiting in a 65-year-old Patient with Psychotic Depression.
    Koch HJ
    Therapie; 2015; 70(6):537-8. PubMed ID: 26242495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
    Post RM; Altshuler LL; Leverich GS; Frye MA; Nolen WA; Kupka RW; Suppes T; McElroy S; Keck PE; Denicoff KD; Grunze H; Walden J; Kitchen CM; Mintz J
    Br J Psychiatry; 2006 Aug; 189():124-31. PubMed ID: 16880481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].
    Watanabe O
    Seishin Shinkeigaku Zasshi; 2014; 116(12):996-1004. PubMed ID: 25823351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder.
    Perry R; Cassagnol M
    Clin Ther; 2009 Jun; 31 Pt 1():1374-404. PubMed ID: 19698900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of an antidepressant.
    Med Lett Drugs Ther; 1993 Mar; 35(892):25-6. PubMed ID: 8441364
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
    Bellantuono C; Vargas M; Mandarelli G; Nardi B; Martini MG
    Hum Psychopharmacol; 2015 May; 30(3):143-51. PubMed ID: 25784291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: Infant and childhood outcomes.
    Hendson L; Shah V; Trkulja S
    Paediatr Child Health; 2021 Aug; 26(5):321-322. PubMed ID: 34336063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple uptake inhibitors: therapeutic potential in depression and beyond.
    Chen Z; Skolnick P
    Expert Opin Investig Drugs; 2007 Sep; 16(9):1365-77. PubMed ID: 17714023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant use during pregnancy: the benefit-risk ratio.
    Koren G; Nordeng H
    Am J Obstet Gynecol; 2012 Sep; 207(3):157-63. PubMed ID: 22425404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.
    Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW
    Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity.
    Murray B; Carpenter J; Dunkley C; Moran TP; Kiernan EA; Rianprakaisang T; Alsukaiti WS; Calello DP; Kazzi Z;
    J Med Toxicol; 2020 Jan; 16(1):12-16. PubMed ID: 31823333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients.
    Erfurth A; Michael N; Stadtland C; Arolt V
    Neuropsychobiology; 2002; 45 Suppl 1():33-6. PubMed ID: 11893875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.